eLife (May 2019)
The dynamic conformational landscape of the protein methyltransferase SETD8
- Shi Chen,
- Rafal P Wiewiora,
- Fanwang Meng,
- Nicolas Babault,
- Anqi Ma,
- Wenyu Yu,
- Kun Qian,
- Hao Hu,
- Hua Zou,
- Junyi Wang,
- Shijie Fan,
- Gil Blum,
- Fabio Pittella-Silva,
- Kyle A Beauchamp,
- Wolfram Tempel,
- Hualiang Jiang,
- Kaixian Chen,
- Robert J Skene,
- Yujun George Zheng,
- Peter J Brown,
- Jian Jin,
- Cheng Luo,
- John D Chodera,
- Minkui Luo
Affiliations
- Shi Chen
- ORCiD
- Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, United States; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States
- Rafal P Wiewiora
- ORCiD
- Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, United States; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States
- Fanwang Meng
- ORCiD
- Drug Discovery and Design Center, CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Nicolas Babault
- Mount Sinai Center for Therapeutics Discovery, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States
- Anqi Ma
- Mount Sinai Center for Therapeutics Discovery, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States
- Wenyu Yu
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
- Kun Qian
- ORCiD
- Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, United States
- Hao Hu
- Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, United States
- Hua Zou
- Takeda California, Science Center Drive, San Diego, United States
- Junyi Wang
- Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States
- Shijie Fan
- Drug Discovery and Design Center, CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; University of Chinese Academy of Sciences, Beijing, China
- Gil Blum
- Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States
- Fabio Pittella-Silva
- ORCiD
- Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States
- Kyle A Beauchamp
- Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States
- Wolfram Tempel
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
- Hualiang Jiang
- Drug Discovery and Design Center, CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; University of Chinese Academy of Sciences, Beijing, China
- Kaixian Chen
- Drug Discovery and Design Center, CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; University of Chinese Academy of Sciences, Beijing, China
- Robert J Skene
- ORCiD
- Takeda California, Science Center Drive, San Diego, United States
- Yujun George Zheng
- Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, United States
- Peter J Brown
- ORCiD
- Structural Genomics Consortium, University of Toronto, Toronto, Canada
- Jian Jin
- ORCiD
- Mount Sinai Center for Therapeutics Discovery, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States
- Cheng Luo
- Drug Discovery and Design Center, CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; University of Chinese Academy of Sciences, Beijing, China
- John D Chodera
- ORCiD
- Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States
- Minkui Luo
- ORCiD
- Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States; Program of Pharmacology, Weill Cornell Medical College of Cornell University, New York, United States
- DOI
- https://doi.org/10.7554/eLife.45403
- Journal volume & issue
-
Vol. 8
Abstract
Elucidating the conformational heterogeneity of proteins is essential for understanding protein function and developing exogenous ligands. With the rapid development of experimental and computational methods, it is of great interest to integrate these approaches to illuminate the conformational landscapes of target proteins. SETD8 is a protein lysine methyltransferase (PKMT), which functions in vivo via the methylation of histone and nonhistone targets. Utilizing covalent inhibitors and depleting native ligands to trap hidden conformational states, we obtained diverse X-ray structures of SETD8. These structures were used to seed distributed atomistic molecular dynamics simulations that generated a total of six milliseconds of trajectory data. Markov state models, built via an automated machine learning approach and corroborated experimentally, reveal how slow conformational motions and conformational states are relevant to catalysis. These findings provide molecular insight on enzymatic catalysis and allosteric mechanisms of a PKMT via its detailed conformational landscape.
Keywords